Skip to main content
Premium Trial:

Request an Annual Quote

Matthew Tindall

Omicia has tapped Matthew Tindall to be its CEO effective immediately. Tindal also joins the company's board of directors. Prior to joining Omicia, he served as general manager of IMS Health's Consumer Solutions division. Before that, he held positions with Celera Genomics, Genzyme Corporation, and Digitas Health.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.